New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Actuate Therapeutics, Inc. (ACTU) vs Seres Therapeutics, Inc. (MCRB)
- Actuate Therapeutics, Inc. ACTU 0.23 +9.52%
- Seres Therapeutics, Inc. MCRB 1.24 −6.77%
Actuate Therapeutics, Inc. and Seres Therapeutics, Inc. are both Biotechnology companies. Actuate Therapeutics, Inc. and Seres Therapeutics, Inc. are of similar size ($13.6M and $12.9M). Across the 7 metrics below, Seres Therapeutics, Inc. leads on 4 and Actuate Therapeutics, Inc. on 3.
Valuation
Profitability
| Metric | ACTU | MCRB | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 100.00% | 70.18% |
| Operating margin | — | (3,656.89%) | 0.00% |
| Net margin | — | (2,209.55%) | 0.00% |
| Free cash flow margin | — | — | 0.00% |
| Return on equity | (364.70%) | (144.35%) | (51.58%) |
| Return on assets | (176.44%) | (44.85%) | (45.91%) |
| Return on invested capital | 0.00% | (1,267.77%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack